Begin with the route, not the dollar sign
An injectable vial, a nasal bottle and an IV appointment are not three sizes of the same retail item. They differ in formulation, administration and the services needed around them. A fair price comparison first groups like offers, then explains what remains different inside each group.
This matters even when two products share an advertised monthly rate. CoreAge Rx lists both injection and nasal options from $93, but matching prices do not establish an equivalent amount, exposure or benefit. The clinician's assessment of the route comes before an attempt to identify the least expensive plan.
Home injection prices describe a supply arrangement
A home-injection offer may bundle a vial, supplies and remote clinical support. To understand the cost, ask for the total amount, concentration, container count and refill interval. The usable period of each container also matters, especially when the commercial offer covers several months.
Avoid dividing the price by an assumed number of injections. That requires guessing a prescription schedule and can make a larger vial seem more economical than it is. Compare the actual quoted supply under the clinician's plan, with any required services included, rather than constructing a treatment plan from the invoice.
A nasal price needs device information
A nasal listing should identify the bottle quantity and pump specifications as well as the financial terms. Equal bottle volumes can contain different concentrations, and equal total amounts do not prove equivalent absorption. A price-per-milliliter figure can describe the purchase but cannot establish clinical equivalence.
Ask the pharmacy about the actual device, storage and usable period. Convenience may influence a patient's preference, particularly if injections are undesirable, but a convenient route still needs an appropriate clinical rationale. It should not be chosen because a marketing page promises faster brain delivery without explaining the relevant evidence.
An IV quote includes a setting
An in-clinic quote can include professional administration, facilities and appointment time. Restore, for example, describes a studio visit with clinician and nursing roles and a broad session-duration range. Those services differ from receiving a product at home, so a higher invoice does not necessarily represent a higher medication price.
Ask the clinic to separate the infusion, consultation, optional additions and membership conditions. Also identify whether the service is NAD+ or a precursor such as NR. A similar wellness purpose does not turn different substances into interchangeable treatments.
Evidence does not transfer automatically
A study of one route cannot establish all outcomes for another. The small IV metabolome study often cited in NAD+ discussions measured how related compounds changed during an infusion; it was not a head-to-head comparison with nasal or home-injection products. Mechanistic interest should remain distinct from demonstrated patient benefit.
Once a clinician has addressed suitability, compare the relevant route on actual terms: first payment, continuing cost, supply, support and practical burden. A useful guide can show all three categories without crowning one universally best. The differences are part of the decision, not noise to remove from the table.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.
- CoreAge Rx NAD+ Injectable Provider
- CoreAge Rx NAD+ Nasal Provider
- Restore Hyper Wellness NAD+ IV Drip Therapy Provider
- Grant et al. 2019: Human plasma and urine metabolome during NAD+ IV infusion Clinical research